A Real-World Pharmacovigilance Study of Cilostazol Based on the Food and Drug Administration Adverse Event Reporting System: A Cross-Sectional Disproportionality Analysis
Fields of Study & Subjects
Pharmacovigilance and Adverse Drug Reactions
Pharmaceutical Practices and Patient Outcomes
Data-Driven Disease Surveillance
Publication details
- Journal / source
- Annals of Vascular Surgery
- Volume
- 127
- Pages
- 391–400
- Publication date
- 18 February 2026
- Language
- EN